GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bioxyne Ltd (ASX:BXN) » Definitions » Valuation Rank

Bioxyne (ASX:BXN) Valuation Rank


View and export this data going back to 2000. Start your Free Trial

What is Bioxyne Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Bioxyne Valuation Rank Related Terms

Thank you for viewing the detailed overview of Bioxyne's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioxyne (ASX:BXN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Bioxyne Ltd (ASX:BXN) » Definitions » Valuation Rank
Comparable Companies
ASX:NUC ASX:AHF ASX:CCO ASX:TFL ASX:BFC ASX:EVE ASX:WOA ASX:PFT ASX:FFF ASX:NGS XSWX:NESN KHC XPAR:BN GIS NSE:NESTLEIND SHSE:603288 LSE:ABF SHSE:600887 SZSE:300999 K
Traded in Other Exchanges
N/A
Address
50 Clarence Street, Suite 506, Level 5, Sydney, NSW, AUS, 2000
Website
https://www.bioxyne.com
Bioxyne Ltd is an Australian life science and health products company. The company is engaged in the development, manufacture, and distribution of consumer dietary supplements based on the proprietary probiotic strain of Lactobacillus Fermentum PCC. Some of its products include Breathe life Science, Dr Watson, BLS Clinics, Mirai Solution, CanXChange etc. It operates in three segments: wholesale sales, Plant based and direct sales. The majority of the revenue is generated from Plant based in the United Kingdom, Europe and Japan.